Prescription of lipid-lowering medications for patients with type 2 diabetes mellitus and risk-associated LDL cholesterol: a nationwide study of guideline adherence from the Swedish National Diabetes Register

BACKGROUND: Management of type 2 diabetes mellitus (T2DM) encompasses intensive glycaemic control, along with treatment of comorbidities and complications to handle the increased risk of cardiovascular disease (CVD). Improved control of LDL-cholesterol (LDL-C) with lipid-lowering medications is asso...

Descripción completa

Detalles Bibliográficos
Autores principales: Karlsson, Sofia Axia, Franzén, Stefan, Svensson, Ann-Marie, Miftaraj, Mervete, Eliasson, Björn, Andersson Sundell, Karolina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260691/
https://www.ncbi.nlm.nih.gov/pubmed/30486824
http://dx.doi.org/10.1186/s12913-018-3707-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260691/
https://www.ncbi.nlm.nih.gov/pubmed/30486824
http://dx.doi.org/10.1186/s12913-018-3707-4

Ejemplares similares